Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquisition |
gptkb:Cure_Vac_AG
|
| gptkbp:clinical_trial |
Phase 2
Phase 3 |
| gptkbp:focus |
drug development
|
| gptkbp:founded |
gptkb:2006
|
| gptkbp:founder |
Roger Tung
|
| gptkbp:headquarters |
gptkb:Lexington,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Concert Pharmaceuticals
|
| gptkbp:partnership |
gptkb:Astra_Zeneca
gptkb:Bristol-Myers_Squibb |
| gptkbp:related_products |
CNP-104
CNP-501 |
| gptkbp:research_focus |
autoimmune diseases
central nervous system disorders metabolic diseases |
| gptkbp:stock_exchange |
gptkb:NASDAQ
|
| gptkbp:stock_symbol |
CNCE
|
| gptkbp:website |
www.concertpharma.com
|
| gptkbp:bfsParent |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:bfsLayer |
4
|